Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.

Por Xin, K Q, Hamajima, K, Sasaki, S, Honsho, A, Tsuji, T, Ishii, N, Cao, X R, Lu, Y, Fukushima, J, Shapshak, P, Kawamoto, S, Okuda, K
Publicado em 1998